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http://dx.doi.org/10.1016/j.jmu.2013Background: To develop a new method for synovial biopsy with ultrasound (US) guidance and a
semiautomatic SuperCore biopsy instrument.
Patients and methods: Twenty-two patients [8 men and 14 women, median age: 57 years
(range: 22e79 years)] with active arthritis or tenosynovitis were enrolled from April 2012 to
October 2012. Each patient had one joint or tendon biopsied. US examination was performed
to determine the optimal synovial site for biopsy. After skin disinfection and local anesthesia, a
portal was established using a trephine needle as needed. An 18-gauge SuperCore biopsy nee-
dle was placed into the target synovial site via the portal or just percutaneously under US guid-
ance using the freehand technique. Repeated needle passes and cuts were made to obtain 3-10
pieces of synovial tissues in each joint. The success of biopsy was defined as the identification
of the synovium on histological examination.
Results: The synovium of 21 joints (10 knees, 6 wrists, 3 ankles, 1 elbow, and 1 metacarpo-
phalangeal joint) were biopsied. One patient had biopsy of the flexor digitorum tendon
sheath. All biopsies obtained adequate amounts of synovial tissues for histologic reading with
a success rate of 100%. The synovial lining was identified in 18 (85.7%) of 21 joints. All pa-
tients tolerated the procedures well, and no complication was observed during the 2-week
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Minimally Invasive Ultrasound-guided Synovial Biopsy 133Conclusion: US-guided synovial biopsy using SuperCore biopsy instrument is a promising
method for synovial research. It has the advantages of being a simple method with mini-
invasiveness and high success rate. The complications are rare.
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Synovial hypertrophy and synovitis are the main charac-
teristics of inflammatory arthritis. Synovium is usually the
area where disease pathogeneses take place, for example,
in cases of rheumatoid arthritis (RA). Thus synovial histol-
ogy provides diagnostic clues and aids in assessment of
disease activity and therapeutic response [1]. In gout and
pseudogout, crystal deposition in the synovium appears as
punctiform hyperechoic spots, namely, bright stippled foci,
on the ultrasound (US) image [2]. In infectious arthritis, the
microscopic examination of the synovium may be valuable
in the detection of causal pathogens, especially for myco-
bacteria, fungi, and varicella-zoster virus. Synovial histol-
ogy also provides diagnostic clues for sarcoidosis,
amyloidosis, and hemochromatosis [1].
However, current synovial biopsy methods such as
arthroscopy and blind needle biopsy are not optimal
because of the complex procedure and higher cost in the
former and sampling error in the latter [3]. Ultrasonography
has been used for assessing both the synovium and tendon
lesions in patients with joint pain and/or swelling [4]. US
could be applied for guiding needle aspiration and injection
[5]. US-guided synovial biopsy has been proposed as a
feasible method for obtaining synovial samples [6e8]. The
instruments used in the former US-guided synovial biopsies
are Tru-cut needles [6,7] or “portal and forceps” [8]. In this
study, we report our experience of an alternative method
for synovial biopsy method under US guidance using a
semiautomatic SuperCore biopsy instrument.Patients and methods
This study was approved by our Institutional Review Board.
Twenty-two patients (8 men and 14 women) with active
arthritis or tenosynovitis were enrolled from April 2012 to
October 2012. The patients’ median age was 57 years
(range: 22e79 years). Sixteen (72.7%) of them were out-
patients and the rest were inpatients. The prebiopsy clin-
ical diagnoses included rheumatoid arthritis (RA; n Z 11),
septic arthritis (nZ 4), systemic lupus erythematosus (SLE,
nZ 2), adult-onset Still’s disease (AOSD, nZ 1), idiopathic
arthritis (nZ 3), and hand flexor tenosynovitis (nZ 1). The
patients with RA, SLE, AOSD, and idiopathic arthritis were
oligo- or polyarthritic, whereas those with septic arthritis
were monoarthritic. The median disease duration was
12 months (range: 0.25e120 months). The diagnosis of RA
was made on the basis of 2010 American College of Rheu-
matology (ACR)/European League Against Rheumatism
criteria for the classification of RA [9]. The diagnosis of
AOSD was made on the basis of the classification criteria
proposed by Yamaguchi in 1992 [10]. The diagnosis of SLE
was made on the basis of the 1997 ACR revised criteria forthe classification of SLE [11]. The indications of synovial
biopsy in the patients with RA, SLE, and AOSD were
assessing disease activity and excluding the possibility of
concomitant joint infection and amyloidosis. The indication
of synovial biopsy in the patients with septic arthritis was
identifying the causal pathogens because the initial syno-
vial fluid cultures failed to yield pathogens. In patients with
idiopathic arthritis and tenosynovitis, synovial biopsies
were performed for diagnosis. Each patient had one joint or
tendon biopsied. The contraindications were skin infection,
bleeding tendency, xylocaine allergy, and uncooperative
patients.
The ultrasonic assessments of joints and the US-guided
synovial biopsies were performed with a General Electric
LOGIC 500 unit (GE, Milwaukee,Wisconsin, USA) using a 6-13-
MHz linear array transducer. The ultrasonic assessments of
joints were performed prior to synovial biopsies in order to
determine the optimal areas of the synovium for histologic
reading. In principle, the most hypertrophied area of the
synoviumwas the target for biopsy. The scanning techniques
used while performing biopsies were dorsal longitudinal
approach in the metacarpophalangeal (MCP) joint, elbow,
and ankle, dorsal longitudinal or transverse approach in the
wrist, and longitudinal lateral or suprapatellar transverse
approach in the knee. The probe position was longitudinal
while performing tendon sheath biopsy.
All biopsies were performed by the author (Lai K-L) who
had an eight-year US experience. A trained nurse or tech-
nician was required for assistance. The operator wore
sterile gloves and a mask. The US probe was covered with a
sterile plastic sleeve. No sedation was used. Skin disinfec-
tion was performed with tincture iodine and 70% alcohol. A
sterile cloth with a hole was placed on the area interested.
Sterile gel was applied to the skin. Local anesthesia with
110 ml of 2% xylocaine was injected into the involved skin,
subcutaneous tissue, and joint cavity or tendon sheath
without air bubbles in the syringe to avoid US artifacts. A
portal was established using a trephine needle (Medical
Device Technologies, Inc., USA) under US guidance in pa-
tients who needed repetitive needle passes to obtain more
than three specimens. An 18-gauge semi-automatic Super-
Core biopsy instrument (Medical Device Technologies, Inc.,
USA), with a needle length of 9 cm, was used to obtain
synovial tissues via the portal (or directly percutaneous
puncture if no portal was established) under US guidance
with the freehand technique (Fig. 1). The operating skills of
this instrument followed the manufactory’s instructions.
Needle passes and cuts were repeated to obtain 3-10 pieces
of synovial tissues in each joint (Figs. 2 and 3) and in the
case of tenosynovitis, three pieces of tendon sheath
(Fig. 4). The optimal amount of synovial specimens was
determined by both the type of synovial research and joint
size. After biopsy, the puncture site was compressed with a
sterile gauze and elastic band, and kept dry until the next
Fig. 1 SuperCore biopsy instrument. (A) A semiautomatic biopsy needle with an 18-gauge diameter and 9-cm length. The
specimen notch (1.2 cm or 2.2 cm) is exposed when the sonographer advances the stylet (left lower). (B) A 17-gauge trephine
needle (upper) with matching stylet (lower) is used to establish a portal. (C) Biopsy of the knee synovium via a portal under
ultrasound guidance with the freehand technique.
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initial 2 hours and avoid heavy physical activities with the
involved joint for 3 days. All patients were followed for 2
weeks to observe any possible complication such as skin and
joint infection, hematoma, and deep vein thrombosis.
The biopsied specimens were immediately fixed in 4%
formaldehyde for up to 24 hours and embedded in paraffin.
Tissue sections were stained with hematoxylin and eosin
and assessed by the same histopathologist. The biopsy
procedure was rated as successful if the synovial tissue wasFig. 2 A 30-year-old woman with rheumatoid arthritis. (A) Right
synovial hypertrophy. (B) A SuperCore biopsy needle is placed into
the biopsy needle (arrow 1), the extent of the specimen notch (betw
4) are indirectly visualized.identified on histological examination. Besides, the lining
layer of the synovium was checked. We also evaluated the
feasibility of obtaining the synovial lining using this biopsy
method by calculating the ratio of synovial lining-positive
joints to total biopsied joints.
Results
The synovium of 21 joints including the knee (nZ 10), wrist
(n Z 6), ankle (n Z 3), elbow (n Z 1), and MCP jointknee suprapatellar transverse ultrasonic scan shows prominent
the synovium via a portal under ultrasound guidance. The tip of
een arrows 2 and 3), and the tip of the trephine needle (arrow
Fig. 3 A 59-year-old man with idiopathic arthritis of the left wrist. (A) Dorsal transverse grayscale (left) and power Doppler
(right) scans show synovial hypertrophy with increased vascularity. (B) A SuperCore biopsy needle is percutaneously placed into the
synovium under ultrasound guidance. The tip of the biopsy needle (arrow 1) and the extent of the specimen notch (between arrows
2 and 3) are indirectly visualized. No trephine needle is used in this case.
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tendon sheath of the hand flexor digitorum tendon. The
MCP joint was the smallest joint biopsied in our study. For
repetitive needle passes and cuts, a portal was establishedFig. 4 A 51-year-old woman with right hand flexor tenosynovitis
tendon shows prominent tendon sheath hypertrophy. (B) A SuperC
phied tendon sheath under ultrasound guidance. The extent of th
alized. MC Z metacarpal bone.in nine patients who received knee biopsies. The length of
the specimen notch of the stylet was set at 1.2 cm for all
joints, and the length of the obtained specimens ranged
from 1 mm to 8 mm. All synovial biopsies obtained an. (A) Longitudinal ultrasound scan of the third flexor digitorum
ore biopsy needle is percutaneously placed into the hypertro-
e specimen notch (between arrows 1 and 2) is indirectly visu-
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success rate of 100% (Fig. 5). Synovial linings were identi-
fied in the specimens from 18 joints with an availability of
85.7%. We took 25e40 minutes to complete a synovial
biopsy procedure per case. All patients tolerated the biopsy
procedures well and did not feel pain due to the filling of
xylocaine in the joint cavity or tendon sheath. The blood
loss during biopsy procedure was minimal (less than one
gauze). No procedure-related complication such as skin and
joint infection, hematoma, and deep vein thrombosis was
observed during the 2-week follow-up period.
We had encountered some technical difficulties in this
study. As the US beam is two dimensional and narrow, it was
difficult to visualize the needle by US imaging using the
freehand technique in the first cases. Although we had
practiced more, the needle position could be easily and
indirectly visualized in the other cases. The accuracy of
needle positioning using the freehand technique was
operator dependent and would be improved by more
practice. Besides, the ability to indirectly visualize the
needle was decreased when the needle direction was more
parallel to the US beam and when the depth of needle
position increased.
Discussion
The histological analysis of synovial biopsies may provide
diagnostic clues for idiopathic arthritis and is valuable in an
early diagnosis of RA [1]. Some studies have documented
the role of synovial pathologies in the assessment of disease
activity and prediction of the response to biologics in RA
[12e14]. There are three methods proposed for synovial
biopsy. The first method is a blind needle technique that
uses a simplified biopsy needle designed by Parker and
Pearson in 1963 [15]. The second is arthroscopy, and the
third is US-guided biopsy using Tru-cut needle [6,7] or
portal and forceps [8]. The major disadvantage of the blind
needle technique is the sampling error. Synovial sites
adjacent to cartilage cannot be easily biopsied by a blind
procedure [1]. Usually the application of blind needleFig. 5 Histological image of the corresponding case in Fig. 2.
The synovial lining is hyperplastic. Chronic inflammation with
apparent plasma cell infiltration and fibrosis in the synovial
sublining are seen (hematoxylin and eosin stain, 400).technique is limited to the knee joint. Arthroscopy remains
the gold standard method for synovial biopsy. It has the
advantage of direct visualization of the synovium and could
harvest a large amount of synovial tissues. The disadvan-
tages of arthroscopy include higher costs and the need for
two portals into a joint [1]. Arthroscopy has been mostly
applied to the knee joint.
As more and more rheumatologists used musculoskeletal
US for management of arthritis in the past decade, US-
guided interventional procedures have been developed in
order to perform accurate aspiration and injection. New
methods of synovial biopsy with US guidance have also been
developed. US-guided synovial biopsy using a Tru-cut nee-
dle with a diameter of 18 gauge equipped with an auto-
mated gun had been proposed by van Vugt et al [6] in 1997,
with a success rate of 100% in seven wrist joints and there
was no complication. In 2006, Marin et al [7] reported their
experience in US-guided synovial biopsy using Tru-cut
needle in 83 patients with monoarthritis of unknown eti-
ology. Synovial tissues were obtained in 78 patients (suc-
cessful rate 94%) from several joint sites, including
shoulder, elbow, wrist, hip, knee, and ankle. No procedure-
related complication occurred.
In 2005, Koski and Helle [8] reported the utility of US-
guided synovial biopsy using portal and forceps, a set of
device borrowed from angiology and gastroenterology, in 37
outpatients with mono- or polyarthritis. Biopsy samples
were taken from small and large joints, bursae, and tendon
sheaths. Representative synovial tissue in adequate
amounts for histopathological evaluation was obtained in
33 out of 37 cases (successful rate 89%). The biopsy pro-
cedures were well tolerated, but a complication of skin
infection was encountered [8].
In this study we use a semi-automatic SuperCore biopsy
instrument for synovial sampling. It is a variant of Tru-cut
needle and has been clinically used for biopsies of liver,
breast tumor, and pleura in Taiwan, but to the best of our
knowledge, it has not been reported for the biopsy of the
synovium yet. Thus, we tried to evaluate the utility of
SuperCore biopsy instrument with US guidance in synovial
biopsy. The manufacturer provides SuperCore biopsy nee-
dles with varied diameter (14e20 gauge) and length (9 cm
or 15 cm). Our experience shows that a needle with a
diameter of 18 gauge and a length of 9 cm is suitable for
most joint sites, from small joint such as the MCP joint to
large joints such as the knee. An exclusive trephine needle
is commercially available from the manufacturer. We
establish a portal using a trephine needle in order to repeat
biopsies if more than three pieces of synovial tissues are
required. Our study demonstrates that US-guided synovial
biopsy using SuperCore biopsy instrument has a success rate
of 100% in 22 patients with active arthritis or tenosynovitis.
It also has a high success rate (85.7%) in obtaining the sy-
novial lining, which is an important target for RA research.
No procedure-related complication is encountered.
The SuperCore biopsy needle has some advantages on
synovial biopsy. It is easier to approach deep synovial areas
adjacent to bone or cartilage where the rheumatoid pannus
is often present. When the sonographer moves the plunger
to advance the stylet, exposing the specimen notch, the
target synovial lesion located at the specimen notch could
be indirectly visualized. The lining layer of the synovium,
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RA, can also be obtained using this biopsy technique. The
SuperCore biopsy needle is a semiautomatic device; hence,
the sonographer can hold the US probe with one hand and
operate the needle with the other hand simultaneously.
The needle is disposable; therefore, there is no risk of
transmission of the infectious disease. US-guided synovial
biopsy using the SuperCore biopsy instrument is a simple
and safe procedure with minimal invasiveness. The punc-
ture wound is minimal. It can be used in outpatients and is
well tolerated by patients. It is applicable to both small and
large joints as well as to the tendon sheath.
This study may have some limitations. First, the utility of
US-guided synovial biopsy using the SuperCore biopsy in-
strument in larger jointsdhip and shoulderdare not clari-
fied in this study although it is theoretically applicable.
Further study is needed to clarify its utility in the hip and
shoulder. Second, this biopsy needle may not be applicable
to smaller joints, such as the proximal interphalangeal
joint, because the specimen notch is relatively too long.
Third, this technique may not work well in the biopsy of
unhypertrophic synovium.
In conclusion, US-guided synovial biopsy using a semi-
automatic SuperCore biopsy instrument is a promising
method for synovial research. It is a simple method with
mini-invasiveness and a high success rate. Complications
are rare. We hope that this simplified synovial biopsy
method could be widely used by rheumatologists in turn to
promote synovial researches to discover the pathogenesis
of early RA and to predict therapeutic response to bi-
ologics. In the future, an individualized treatment could be
tailored according to the synovial histology.
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